JAMP LENALIDOMIDE
Identification of Jamp Lenalidomide
| No description |
Google image searchProduct monograph
Active ingredient
lenalidomide, 15 MG
DIN: 02506165
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 02-FEB-2022
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AX — Other immunosuppressants (ATC, ATC/DDD)
- L04AX04 — LENALIDOMIDE (ATC/DDD)
Reference brand drug: Revlimid
Pharmaceutical standard: MFR
